Search

everythinglearnresearchcommunity

for

Search:↓

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Hair loss in women can be treated with hormone therapy.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Treating hyperprolactinemia can help manage PCOS symptoms.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

PSA can help diagnose high androgen levels in women.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.